{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T06:05:39Z","timestamp":1773468339863,"version":"3.50.1"},"reference-count":25,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006544","name":"Israeli Ministry of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006544","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Rapid and accurate detection of drug-resistant tuberculosis (DR-TB) is critical for effective treatment and containment. The Xpert\u00ae MTB\/XDR (GXXDR) assay is designed to detect Mycobacterium tuberculosis complex (MTBC) and resistance to isoniazid and second-line anti-TB drugs directly from clinical specimens. We evaluated the clinical performance of GXXDR using 61 MTBC-positive specimens with available phenotypic drug susceptibility testing results. GXXDR results were compared to a phenotypic drug susceptibility test (pDST) and whole-genome sequencing (WGS) to assess sensitivity, specificity, and concordance. Resistance to isoniazid, fluoroquinolones, amikacin, capreomycin, and ethionamide was analyzed. Sensitivity comparisons between GXXDR, WGS, pDST, and manufacturer data were performed using Fisher\u2019s exact and Tango tests. GXXDR demonstrated a high specificity for most drugs and a strong sensitivity for isoniazid (93.8%) and fluoroquinolone (92.3%), consistent with manufacturer reports. In contrast, the sensitivity for amikacin (58.3%), capreomycin (35.7%), and ethionamide (27.3%) was significantly lower than stated by the manufacturer (91.9%, 84.0% and 64.7%, respectively), likely due to resistance mutations outside the assay\u2019s target regions. Sensitivity concordance of GXXDR with WGS was high for all drugs, except ethionamide. The GXXDR assay enables rapid and reliable detection of isoniazid and fluoroquinolone resistance in clinical settings, though sensitivity for certain second-line drugs may be affected by regional genetic diversity. These findings underscore the importance of integrating local epidemiological data to optimize molecular diagnostics for DR-TB.<\/jats:p>","DOI":"10.3390\/ijms27062597","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:23:03Z","timestamp":1773307383000},"page":"2597","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-World Assessment of the Xpert MTB\/XDR for Detecting Isoniazid and Second-Line Drug Resistance Among TB Patients"],"prefix":"10.3390","volume":"27","author":[{"given":"Andrei","family":"Makhon","sequence":"first","affiliation":[{"name":"National Public Health Laboratory, Public Health Directorate, Ministry of Health, Tel Aviv 6810416, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sivan","family":"Fuchs","sequence":"additional","affiliation":[{"name":"National Public Health Laboratory, Public Health Directorate, Ministry of Health, Tel Aviv 6810416, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mor","family":"Rubinstein","sequence":"additional","affiliation":[{"name":"National Public Health Laboratory, Public Health Directorate, Ministry of Health, Tel Aviv 6810416, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Brodsky","sequence":"additional","affiliation":[{"name":"Clalit Health Services, Regional Laboratory of Haifa and Western Galilee, Nesher 3688847, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1210-7342","authenticated-orcid":false,"given":"Zeev","family":"Dveyrin","sequence":"additional","affiliation":[{"name":"National Public Health Laboratory, Public Health Directorate, Ministry of Health, Tel Aviv 6810416, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7703-4386","authenticated-orcid":false,"given":"Noa","family":"Tejman-Yarden","sequence":"additional","affiliation":[{"name":"National Public Health Laboratory, Public Health Directorate, Ministry of Health, Tel Aviv 6810416, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yelena","family":"Losev","sequence":"additional","affiliation":[{"name":"National Public Health Laboratory, Public Health Directorate, Ministry of Health, Tel Aviv 6810416, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"21633","DOI":"10.1021\/acs.jmedchem.4c02876","article-title":"Move over COVID, Tuberculosis Is Once again the Leading Cause of Death from a Single Infectious Disease","volume":"67","author":"Berida","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_2","unstructured":"(2026, February 15). Global Tuberculosis Report. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240101531."},{"key":"ref_3","unstructured":"(2026, February 15). Tuberculosis & AIDS Department, Available online: https:\/\/www.gov.il\/he\/pages\/disease-tuberculosis?chapterIndex=6."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"240232","DOI":"10.1183\/20734735.0232-2024","article-title":"Update in tuberculosis treatment: A scoping review of current practices","volume":"21","author":"Lopes","year":"2025","journal-title":"Breathe"},{"key":"ref_5","unstructured":"(2026, February 15). WHO Operational Handbook on Tuberculosis: Module 3: Diagnosis: Rapid Diagnostics for Tuberculosis Detection. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240089501."},{"key":"ref_6","unstructured":"(2026, February 15). Catalogue of Mutations in Mycobacterium tuberculosis Complex and Their Association with Drug Resistance, 2nd ed. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240082410."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"15333","DOI":"10.1038\/s41598-021-94297-z","article-title":"Implementation of whole genome sequencing for tuberculosis diagnostics in a low-middle income, high MDR-TB burden country","volume":"11","author":"Vogel","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_8","unstructured":"(2026, February 15). Xpert MTB_RIF ENGLISH Package Insert 301-0191 Rev K. Available online: https:\/\/infomine.cepheid.com\/sites\/default\/files\/2023-07\/Xpert%20MTB_RIF%20ENGLISH%20Package%20Insert%20301-0191%20Rev%20K.pdf."},{"key":"ref_9","unstructured":"(2026, February 15). Xpert MTB\/RIF Ultra. Available online: https:\/\/infomine.cepheid.com\/sites\/default\/files\/2025-10\/Xpert%20MTB_RIF%20Ultra%20CE%20IVD%20ENGLISH%20Package%20Insert%20301-5987%20Rev%20N_0.pdf."},{"key":"ref_10","unstructured":"(2026, February 15). Xpert MTB-XDR ENGLISH Package Insert 302-3514 Rev, C. Available online: https:\/\/www.cepheid.com\/content\/dam\/www-cepheid-com\/documents\/package-insert-files\/Xpert%20MTB-XDR%20ENGLISH%20Package%20Insert%20302-3514%20Rev%20C.pdf."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/1574-6968.12597","article-title":"Crucial components of Mycobacterium type II fatty acid biosynthesis (Fas-II) and their inhibitors","volume":"360","author":"Duan","year":"2014","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1365-2958.2006.05467.x","article-title":"Mechanisms of action of isoniazid","volume":"62","author":"Timmins","year":"2006","journal-title":"Mol. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JCM.02314-20","article-title":"Xpert MTB\/XDR: A 10-Color Reflex Assay Suitable for Point-of-Care Settings to Detect Isoniazid, Fluoroquinolone, and Second-Line-Injectable-Drug Resistance Directly from Mycobacterium tuberculosis-Positive Sputum","volume":"59","author":"Cao","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1073\/pnas.1525055113","article-title":"Fluoroquinolone interactions with Mycobacterium tuberculosis gyrase: Enhancing drug activity against wild-type and resistant gyrase","volume":"113","author":"Aldred","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Malik, S., Willby, M., Sikes, D., Tsodikov, O.V., and E Posey, J. (2012). New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: Functional genetic analysis of gyrA and gyrB mutations. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0039754"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1128\/AAC.00287-09","article-title":"Fluoroquinolone resistance in Mycobacterium tuberculosis mutations in, gyrA and gyrB","volume":"53","author":"Martin","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"19665","DOI":"10.1073\/pnas.1907631116","article-title":"Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance","volume":"116","author":"Safi","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ja.2017.126","article-title":"New antituberculous drugs derived from natural products: Current perspectives and issues in antituberculous drug development","volume":"71","author":"Igarashi","year":"2017","journal-title":"J. Antibiot."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/antibiotics3030317","article-title":"Drug Resistance Mechanisms in Mycobacterium tuberculosis","volume":"3","author":"Palomino","year":"2014","journal-title":"Antibiotics"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.5588\/ijtld.12.0375","article-title":"Epidemiology of extra-pulmonary tuberculosis in Israel, 1999\u20132010","volume":"17","author":"Mor","year":"2013","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_21","unstructured":"Kent, P.T., and Kubica, G.P. (1985). Public Health Mycobacteriology: A Guide for the Level III Laboratory."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1801163","DOI":"10.1183\/13993003.01163-2018","article-title":"Whole genome sequencing of Mycobacterium tuberculosis","volume":"52","author":"Cabibbe","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_23","unstructured":"Andrews, S. (2026, February 15). FastQC: A Quality Control Tool for High Throughput Sequence Data. Available online: https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13059-019-1891-0","article-title":"Improved metagenomic analysis with Kraken 2","volume":"20","author":"Wood","year":"2019","journal-title":"Genome Biol."},{"key":"ref_25","unstructured":"Garrison, E., and Marth, G. (2012). Haplotype-based variant detection from short-read sequencing. arXiv."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/6\/2597\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T05:17:52Z","timestamp":1773465472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/6\/2597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["ijms27062597"],"URL":"https:\/\/doi.org\/10.3390\/ijms27062597","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]}}}